Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02088164
Recruitment Status : Completed
First Posted : March 14, 2014
Last Update Posted : March 14, 2014
Sponsor:
Information provided by (Responsible Party):
National Taiwan University Hospital

Brief Summary:
To determine the long-term survival outcome of subjects who had various PSA levels at screening

Condition or disease
Prostate Cancer

Layout table for study information
Study Type : Observational
Actual Enrollment : 27741 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men
Study Start Date : February 2012
Actual Primary Completion Date : April 2012

Resource links provided by the National Library of Medicine


Group/Cohort
Healthy men
Healthy men who received PSA screening



Primary Outcome Measures :
  1. Diagnosis of prostate cancer [ Time Frame: 20 years (average) ]

Secondary Outcome Measures :
  1. Cancer-specific death [ Time Frame: 20 years (average) ]
  2. Overall survival [ Time Frame: 20 years (average) ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   41 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Taiwanese healthy men who are older than 40 years
Criteria

Inclusion Criteria:

  • Health men who received PSA screening at NTUH and CGMH

Exclusion Criteria:

  • Prior history of prostate cancer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02088164


Locations
Layout table for location information
Taiwan
National Taiwan University Hospital
Taipei city, Taiwan, 100
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Yeong-Shiau Pu, PhD National Taiwan University Hospital
Layout table for additonal information
Responsible Party: National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT02088164    
Other Study ID Numbers: 200809020
First Posted: March 14, 2014    Key Record Dates
Last Update Posted: March 14, 2014
Last Verified: March 2014
Keywords provided by National Taiwan University Hospital:
PSA,
asian men,
survival
Additional relevant MeSH terms:
Layout table for MeSH terms
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Prostatic Diseases